13F Holdings
中文EN

CC Chemours Co

Chemicals & Allied Products · NYSE · SEC CIK 1627223 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY0.1%
TTM net income YoY56.0%
TTM EPS YoY56.2%
Revenue 3-yr CAGR-1.2%
Net income 3-yr CAGR—

Margins

Gross margin15.2%
Operating margin—
Net margin-2.6%
FCF margin3.6%
EBITDA margin—

Returns

ROE-71.8%
ROA-2.1%
ROIC (approx.)—
Asset turnover0.79x

Leverage & solvency

Liabilities / assets97.9%
Debt / equity24.73x
Current ratio1.81x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-2.60x
Accruals ratio-7.5%
Payout ratio—
Capex / revenue3.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$5.81B$5.78B$6.08B$6.83B$6.34B
Cost of revenue$4.91B$4.64B$4.78B$5.21B$4.96B
Gross profit$902.00M$1.14B$1.30B$1.62B$1.38B
R&D expense$108.00M$109.00M$108.00M$118.00M$107.00M
SG&A expense$799.00M$598.00M$1.29B$710.00M$592.00M
Interest expense$269.00M$263.00M$208.00M$163.00M$185.00M
Pretax income-$277.00M$106.00M-$318.00M$741.00M$676.00M
Income tax$109.00M$37.00M-$66.00M$163.00M$68.00M
Net income-$386.00M$69.00M-$253.00M$578.00M$608.00M
EPS (basic)-2.570.46-1.703.723.69
EPS (diluted)-2.570.46-1.703.653.60
Dividends declared per share0.511.001.001.001.00
Weighted avg. shares (diluted)150.24M150.17M148.91M158.30M168.70M
Balance sheet
Cash & equivalents$670.00M$763.00M$1.20B$1.30B$1.55B
Receivables$562.00M$619.00M$622.00M$509.00M$644.00M
Inventory$1.57B$1.46B$1.35B$1.40B$1.10B
Current assets$3.00B$3.02B$3.84B$3.21B$3.35B
PP&E, net$3.08B$3.19B$3.21B$3.17B$3.15B
Goodwill$46.00M$46.00M$102.00M$102.00M$102.00M
Intangibles$2.00M$3.00M$3.00M$13.00M$6.00M
Total assets$7.38B$7.51B$8.24B$7.64B$7.55B
Current liabilities$1.69B$1.82B$2.49B$1.89B$1.86B
Short-term debt$42.00M$54.00M$51.00M$43.00M$25.00M
Long-term debt$4.10B$4.06B$3.99B$3.59B$3.72B
Total debt$4.14B$4.11B$4.04B$3.63B$3.75B
Total liabilities$7.13B$6.94B$7.52B$6.53B$6.47B
Shareholders' equity$250.00M$571.00M$721.00M$1.11B$1.08B
Net debt$3.47B$3.35B$2.84B$2.33B$2.20B
Shares outstanding149.89M149.43M148.59M148.50M161.05M
Cash flow statement
Operating cash flow$264.00M-$633.00M$556.00M$755.00M$814.00M
Capital expenditure$213.00M$360.00M$370.00M$307.00M$277.00M
Free cash flow$51.00M-$993.00M$186.00M$448.00M$537.00M
Investing cash flow-$206.00M-$353.00M-$229.00M-$284.00M$220.00M
Financing cash flow-$126.00M-$36.00M$172.00M-$686.00M-$554.00M
Depreciation & amortization$340.00M$292.00M$309.00M$291.00M$317.00M
Stock-based compensation$21.00M$15.00M$18.00M$27.00M$34.00M
Dividends paid$78.00M$148.00M$149.00M$154.00M$164.00M
Share buybacks——$69.00M$495.00M$173.00M

Free plan shows the latest 5 periods; Pro shows all 13 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.